kanitinib
Small moleculeexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2019 (NCT04093466)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Hepatocyte growth factor receptorINHIBITOR
MET inhibitor
KDR inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04093466 | Phase 1 | Nov 30, 2019 | Beijing Konruns Pharmaceutical Co., Ltd., Capital Medical University, Chinese Academy of Medical Sciences, Sichuan University, Tsinghua University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Beijing Konruns Pharmaceutical Co., Ltd. | For profit | 1 | 1 | 1 | 2019 |
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Sichuan University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Tsinghua University | Academic/Hospital | 1 | 0 | 1 | 2019 |
5 organizations
Page 1 / 1